Louisiana · 2026 Regular Session · Bill
HB 870: INSURANCE/HEALTH: Provides relative to formulary placement and cost-sharing requirements for certain generic drugs and biosimilars (EN NO IMPACT See Note)
Enacted Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 870 is a bill introduced in the Louisiana House on February 27, 2026. According to its official title, it concerns: INSURANCE/HEALTH: Provides relative to formulary placement and cost-sharing requirements for certain generic drugs and biosimilars (EN NO IMPACT See Note). Primary sponsor: Chris Turner (Republican). Most recent recorded action (June 12, 2026): Signed by the Governor. Becomes Act No. 907.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Republican 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Chris Turner | Primary sponsor | Republican | House | 12 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Signed by the Governor. Becomes Act No. 907.
- Effective date: 08/01/2026.
- Sent to the Governor for executive approval.
- Enrolled and signed by the Speaker of the House.
- Signed by the President of the Senate.
- Conference Committee Report read, roll called, yeas 94, nays 0. The Conference Committee Report was adopted.
- Notice House adopted the Conference Committee Report.
- Conference Committee Report read; adopted by a vote of 36 yeas and 0 nays.
- Notice of Senate adoption of Conference Committee Report.
- Conference Committee report received. Lies over under the rules.
- Conference committee report received.
- Scheduled for floor debate on 05/312026.
Showing 12 most recent of 40 actions. Full history